 Wei Perng
Concepts (408)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adiposity | 34 | 2025 | 518 | 8.150 |
Why?
| | Prenatal Exposure Delayed Effects | 24 | 2025 | 605 | 6.500 |
Why?
| | Body Mass Index | 53 | 2025 | 2375 | 4.610 |
Why?
| | Pediatric Obesity | 16 | 2025 | 590 | 3.870 |
Why?
| | Diabetes, Gestational | 12 | 2025 | 316 | 3.360 |
Why?
| | Environmental Pollutants | 10 | 2025 | 157 | 3.010 |
Why?
| | Cardiovascular Diseases | 14 | 2025 | 2104 | 2.910 |
Why?
| | Pregnancy | 69 | 2025 | 6726 | 2.890 |
Why?
| | Birth Weight | 18 | 2024 | 514 | 2.840 |
Why?
| | Metabolomics | 14 | 2024 | 678 | 2.730 |
Why?
| | Biomarkers | 33 | 2025 | 4144 | 2.640 |
Why?
| | Diet | 20 | 2025 | 1274 | 2.550 |
Why?
| | Non-alcoholic Fatty Liver Disease | 8 | 2023 | 279 | 2.470 |
Why?
| | Weight Gain | 11 | 2023 | 519 | 2.320 |
Why?
| | DNA Methylation | 12 | 2024 | 640 | 2.110 |
Why?
| | Child | 87 | 2025 | 21822 | 2.090 |
Why?
| | Polycystic Ovary Syndrome | 5 | 2025 | 176 | 2.090 |
Why?
| | Obesity | 26 | 2025 | 2982 | 2.070 |
Why?
| | Body Composition | 15 | 2023 | 679 | 1.920 |
Why?
| | Leptin | 10 | 2024 | 236 | 1.920 |
Why?
| | Endocrine Disruptors | 4 | 2024 | 40 | 1.910 |
Why?
| | Epigenesis, Genetic | 10 | 2024 | 657 | 1.900 |
Why?
| | Female | 125 | 2025 | 72796 | 1.750 |
Why?
| | Mothers | 9 | 2024 | 752 | 1.750 |
Why?
| | Environmental Exposure | 7 | 2024 | 572 | 1.640 |
Why?
| | Child Health | 5 | 2024 | 154 | 1.620 |
Why?
| | Metabolic Syndrome | 5 | 2021 | 354 | 1.610 |
Why?
| | Insulin | 10 | 2025 | 2406 | 1.550 |
Why?
| | Prospective Studies | 36 | 2025 | 7572 | 1.510 |
Why?
| | Adolescent | 57 | 2025 | 21384 | 1.480 |
Why?
| | Overnutrition | 3 | 2021 | 30 | 1.480 |
Why?
| | Child, Preschool | 48 | 2025 | 11000 | 1.470 |
Why?
| | Hypertension, Pregnancy-Induced | 6 | 2025 | 68 | 1.470 |
Why?
| | Humans | 148 | 2025 | 136769 | 1.460 |
Why?
| | Infant, Newborn | 34 | 2024 | 6032 | 1.430 |
Why?
| | Overweight | 8 | 2024 | 557 | 1.410 |
Why?
| | Body Weight | 7 | 2022 | 985 | 1.400 |
Why?
| | Metabolome | 6 | 2024 | 350 | 1.360 |
Why?
| | Premature Birth | 6 | 2022 | 331 | 1.330 |
Why?
| | Stress, Psychological | 3 | 2023 | 1097 | 1.320 |
Why?
| | Body Height | 5 | 2018 | 199 | 1.240 |
Why?
| | Risk Factors | 28 | 2025 | 10326 | 1.220 |
Why?
| | Long Interspersed Nucleotide Elements | 3 | 2013 | 31 | 1.210 |
Why?
| | Cohort Studies | 25 | 2025 | 5701 | 1.210 |
Why?
| | Health Status | 3 | 2024 | 788 | 1.200 |
Why?
| | Fetal Blood | 6 | 2024 | 327 | 1.190 |
Why?
| | Pregnancy Outcome | 5 | 2022 | 412 | 1.150 |
Why?
| | Blood Pressure | 10 | 2025 | 1774 | 1.150 |
Why?
| | Diabetes Mellitus, Type 2 | 6 | 2023 | 2518 | 1.150 |
Why?
| | Blood Glucose | 12 | 2025 | 2181 | 1.120 |
Why?
| | Insulin Resistance | 11 | 2025 | 1203 | 1.100 |
Why?
| | Waist Circumference | 9 | 2022 | 143 | 1.090 |
Why?
| | Fluorocarbons | 3 | 2025 | 117 | 1.060 |
Why?
| | Maternal Nutritional Physiological Phenomena | 5 | 2025 | 176 | 1.060 |
Why?
| | Male | 74 | 2025 | 67313 | 1.060 |
Why?
| | Anti-Mullerian Hormone | 2 | 2025 | 57 | 1.010 |
Why?
| | Metabolic Diseases | 4 | 2021 | 108 | 1.000 |
Why?
| | Amino Acids, Branched-Chain | 4 | 2022 | 36 | 0.960 |
Why?
| | Puberty | 4 | 2022 | 146 | 0.960 |
Why?
| | Adiponectin | 6 | 2025 | 244 | 0.960 |
Why?
| | Nutritional Status | 4 | 2020 | 344 | 0.960 |
Why?
| | Mexico | 11 | 2023 | 225 | 0.950 |
Why?
| | Maternal Exposure | 5 | 2025 | 188 | 0.940 |
Why?
| | Phthalic Acids | 3 | 2024 | 40 | 0.920 |
Why?
| | Adult | 44 | 2025 | 37631 | 0.910 |
Why?
| | C-Reactive Protein | 8 | 2025 | 408 | 0.900 |
Why?
| | Child Development | 7 | 2024 | 464 | 0.880 |
Why?
| | Skinfold Thickness | 4 | 2018 | 46 | 0.870 |
Why?
| | Young Adult | 26 | 2025 | 13129 | 0.860 |
Why?
| | Lead | 2 | 2021 | 63 | 0.790 |
Why?
| | Psychological Tests | 1 | 2023 | 140 | 0.790 |
Why?
| | Sexual Maturation | 2 | 2019 | 55 | 0.760 |
Why?
| | Self Report | 4 | 2023 | 822 | 0.750 |
Why?
| | Pregnancy Proteins | 1 | 2022 | 36 | 0.750 |
Why?
| | Azocines | 1 | 2021 | 8 | 0.740 |
Why?
| | Hyaenidae | 1 | 2021 | 4 | 0.730 |
Why?
| | Insulins | 1 | 2022 | 37 | 0.730 |
Why?
| | Infant | 28 | 2024 | 9397 | 0.720 |
Why?
| | Longitudinal Studies | 17 | 2025 | 2829 | 0.720 |
Why?
| | Cardiovascular System | 1 | 2023 | 137 | 0.720 |
Why?
| | Ecology | 1 | 2022 | 117 | 0.710 |
Why?
| | Maternal Behavior | 1 | 2021 | 78 | 0.700 |
Why?
| | Lipid Metabolism | 1 | 2024 | 512 | 0.690 |
Why?
| | Biological Evolution | 2 | 2022 | 467 | 0.690 |
Why?
| | Hyperinsulinism | 1 | 2021 | 121 | 0.670 |
Why?
| | Triglycerides | 7 | 2023 | 524 | 0.660 |
Why?
| | Massachusetts | 6 | 2025 | 171 | 0.660 |
Why?
| | Prediabetic State | 1 | 2023 | 253 | 0.640 |
Why?
| | Racism | 1 | 2022 | 135 | 0.640 |
Why?
| | Social Environment | 1 | 2021 | 295 | 0.630 |
Why?
| | Placenta | 3 | 2023 | 749 | 0.620 |
Why?
| | Lipids | 3 | 2020 | 665 | 0.610 |
Why?
| | Islets of Langerhans | 2 | 2023 | 803 | 0.600 |
Why?
| | Epidemiology | 1 | 2018 | 33 | 0.590 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 2018 | 68 | 0.580 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2018 | 13 | 0.570 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2018 | 47 | 0.570 |
Why?
| | Menopause | 4 | 2025 | 319 | 0.560 |
Why?
| | Linear Models | 8 | 2024 | 846 | 0.560 |
Why?
| | Adipose Tissue | 5 | 2020 | 630 | 0.560 |
Why?
| | Cholesterol | 4 | 2023 | 410 | 0.560 |
Why?
| | Insulin-Like Growth Factor II | 1 | 2017 | 22 | 0.550 |
Why?
| | Homeostasis | 2 | 2021 | 619 | 0.550 |
Why?
| | Body Fluid Compartments | 1 | 2017 | 6 | 0.550 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2017 | 39 | 0.550 |
Why?
| | Socioeconomic Factors | 8 | 2024 | 1282 | 0.550 |
Why?
| | Sex Characteristics | 2 | 2020 | 759 | 0.540 |
Why?
| | Inflammation | 5 | 2025 | 2835 | 0.540 |
Why?
| | Breast Feeding | 5 | 2024 | 439 | 0.530 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2018 | 139 | 0.520 |
Why?
| | Bone and Bones | 1 | 2019 | 316 | 0.510 |
Why?
| | Androgens | 1 | 2018 | 187 | 0.510 |
Why?
| | Feeding Behavior | 3 | 2023 | 648 | 0.500 |
Why?
| | Anthropometry | 6 | 2022 | 213 | 0.490 |
Why?
| | MicroRNAs | 1 | 2022 | 692 | 0.490 |
Why?
| | Fatty Liver | 3 | 2025 | 243 | 0.480 |
Why?
| | Micronutrients | 2 | 2013 | 92 | 0.470 |
Why?
| | Fetal Development | 1 | 2018 | 296 | 0.470 |
Why?
| | Diabetes Mellitus | 2 | 2023 | 1032 | 0.460 |
Why?
| | Gestational Age | 4 | 2024 | 902 | 0.460 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 316 | 0.460 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 2 | 2025 | 82 | 0.460 |
Why?
| | alpha-Linolenic Acid | 1 | 2014 | 8 | 0.460 |
Why?
| | Maternal Welfare | 1 | 2014 | 21 | 0.460 |
Why?
| | Colombia | 6 | 2018 | 41 | 0.450 |
Why?
| | Carbon Isotopes | 2 | 2025 | 144 | 0.440 |
Why?
| | Hypertension | 3 | 2025 | 1284 | 0.440 |
Why?
| | Hyperhomocysteinemia | 1 | 2013 | 27 | 0.430 |
Why?
| | Alu Elements | 1 | 2013 | 28 | 0.430 |
Why?
| | Abdominal Fat | 3 | 2023 | 41 | 0.420 |
Why?
| | Homocysteine | 1 | 2013 | 156 | 0.410 |
Why?
| | Iron, Dietary | 1 | 2013 | 22 | 0.400 |
Why?
| | Intra-Abdominal Fat | 3 | 2023 | 91 | 0.400 |
Why?
| | Age Factors | 6 | 2025 | 3284 | 0.390 |
Why?
| | Fatty Acids | 2 | 2020 | 442 | 0.390 |
Why?
| | Growth Disorders | 1 | 2013 | 86 | 0.390 |
Why?
| | Endotoxins | 2 | 2023 | 220 | 0.380 |
Why?
| | Poliomyelitis | 1 | 2012 | 37 | 0.380 |
Why?
| | Follow-Up Studies | 8 | 2022 | 5106 | 0.370 |
Why?
| | American Heart Association | 2 | 2024 | 306 | 0.370 |
Why?
| | Infertility | 2 | 2022 | 55 | 0.370 |
Why?
| | Health Behavior | 4 | 2024 | 756 | 0.370 |
Why?
| | Postpartum Period | 3 | 2020 | 337 | 0.360 |
Why?
| | Sex Factors | 4 | 2019 | 2060 | 0.350 |
Why?
| | Diseases in Twins | 1 | 2012 | 169 | 0.350 |
Why?
| | Twins | 1 | 2012 | 242 | 0.340 |
Why?
| | Boston | 4 | 2025 | 91 | 0.340 |
Why?
| | Food Hypersensitivity | 2 | 2024 | 183 | 0.340 |
Why?
| | Causality | 2 | 2021 | 126 | 0.330 |
Why?
| | Cross-Sectional Studies | 9 | 2025 | 5423 | 0.320 |
Why?
| | Logistic Models | 4 | 2025 | 2067 | 0.320 |
Why?
| | Atherosclerosis | 1 | 2013 | 415 | 0.310 |
Why?
| | Age of Onset | 2 | 2022 | 518 | 0.310 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2023 | 3710 | 0.310 |
Why?
| | C-Peptide | 2 | 2021 | 163 | 0.310 |
Why?
| | Exercise | 4 | 2025 | 2043 | 0.300 |
Why?
| | Interleukin-6 | 4 | 2025 | 778 | 0.290 |
Why?
| | Principal Component Analysis | 3 | 2019 | 194 | 0.290 |
Why?
| | Adipokines | 2 | 2025 | 49 | 0.290 |
Why?
| | Child Care | 2 | 2024 | 31 | 0.280 |
Why?
| | United States | 8 | 2025 | 14690 | 0.260 |
Why?
| | Multivariate Analysis | 5 | 2016 | 1507 | 0.240 |
Why?
| | Alkanesulfonic Acids | 2 | 2025 | 41 | 0.240 |
Why?
| | Regression Analysis | 3 | 2018 | 1022 | 0.240 |
Why?
| | Dietary Sugars | 1 | 2025 | 16 | 0.240 |
Why?
| | Liver | 3 | 2023 | 1940 | 0.240 |
Why?
| | Colorado | 5 | 2024 | 4516 | 0.230 |
Why?
| | Odds Ratio | 3 | 2023 | 1065 | 0.230 |
Why?
| | Incidence | 3 | 2023 | 2792 | 0.230 |
Why?
| | Residence Characteristics | 2 | 2025 | 349 | 0.230 |
Why?
| | Middle Aged | 12 | 2025 | 33228 | 0.230 |
Why?
| | Genome-Wide Association Study | 2 | 2023 | 1428 | 0.230 |
Why?
| | Hyperglycemia | 2 | 2018 | 347 | 0.230 |
Why?
| | Child Behavior | 2 | 2024 | 246 | 0.230 |
Why?
| | Hyperandrogenism | 1 | 2025 | 21 | 0.230 |
Why?
| | Parabens | 1 | 2024 | 10 | 0.230 |
Why?
| | Air Pollution | 2 | 2020 | 315 | 0.220 |
Why?
| | Genetic Association Studies | 2 | 2019 | 375 | 0.220 |
Why?
| | Prevalence | 3 | 2025 | 2711 | 0.220 |
Why?
| | Choline | 1 | 2025 | 127 | 0.220 |
Why?
| | Pregnancy Complications | 3 | 2020 | 524 | 0.220 |
Why?
| | Vulnerable Populations | 1 | 2025 | 162 | 0.210 |
Why?
| | Phenols | 1 | 2024 | 97 | 0.210 |
Why?
| | Birth Order | 1 | 2023 | 14 | 0.210 |
Why?
| | Air Pollutants | 2 | 2020 | 427 | 0.210 |
Why?
| | Asthma | 4 | 2023 | 2282 | 0.200 |
Why?
| | Parturition | 2 | 2022 | 71 | 0.200 |
Why?
| | Cannabidiol | 1 | 2024 | 119 | 0.200 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2025 | 2184 | 0.200 |
Why?
| | Immunoglobulin E | 1 | 2024 | 342 | 0.190 |
Why?
| | Phenotype | 2 | 2022 | 3189 | 0.190 |
Why?
| | Vegetables | 2 | 2020 | 156 | 0.190 |
Why?
| | Insulin, Regular, Human | 1 | 2022 | 43 | 0.190 |
Why?
| | Dronabinol | 1 | 2024 | 226 | 0.190 |
Why?
| | Michigan | 2 | 2020 | 108 | 0.190 |
Why?
| | Adolescent Behavior | 2 | 2024 | 529 | 0.180 |
Why?
| | Toxoplasmosis, Animal | 1 | 2021 | 6 | 0.180 |
Why?
| | Carbohydrates | 1 | 2021 | 65 | 0.180 |
Why?
| | Plethysmography | 2 | 2022 | 106 | 0.180 |
Why?
| | Hand Strength | 1 | 2022 | 122 | 0.180 |
Why?
| | Lysine | 1 | 2024 | 294 | 0.180 |
Why?
| | Antibodies, Protozoan | 1 | 2021 | 36 | 0.180 |
Why?
| | Cholesterol, LDL | 2 | 2022 | 365 | 0.180 |
Why?
| | Educational Status | 1 | 2023 | 470 | 0.180 |
Why?
| | Glucose Tolerance Test | 2 | 2025 | 364 | 0.180 |
Why?
| | Health Status Disparities | 1 | 2024 | 283 | 0.180 |
Why?
| | Toxoplasma | 1 | 2021 | 42 | 0.180 |
Why?
| | Sarcopenia | 1 | 2022 | 83 | 0.180 |
Why?
| | Testosterone | 1 | 2025 | 401 | 0.180 |
Why?
| | Latin America | 1 | 2021 | 93 | 0.180 |
Why?
| | Cats | 1 | 2021 | 209 | 0.170 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2023 | 547 | 0.170 |
Why?
| | Protective Factors | 1 | 2021 | 93 | 0.170 |
Why?
| | Dermatitis, Atopic | 1 | 2024 | 329 | 0.170 |
Why?
| | Selection, Genetic | 1 | 2022 | 264 | 0.170 |
Why?
| | Scotland | 1 | 2019 | 18 | 0.160 |
Why?
| | Pre-Eclampsia | 1 | 2022 | 189 | 0.160 |
Why?
| | Problem Behavior | 1 | 2021 | 102 | 0.160 |
Why?
| | Precision Medicine | 1 | 2023 | 426 | 0.160 |
Why?
| | Acetylcarnitine | 1 | 2018 | 5 | 0.150 |
Why?
| | Aminoisobutyric Acids | 1 | 2018 | 7 | 0.150 |
Why?
| | Data Interpretation, Statistical | 1 | 2021 | 363 | 0.150 |
Why?
| | Hydroxyproline | 1 | 2018 | 21 | 0.150 |
Why?
| | Health Surveys | 1 | 2021 | 513 | 0.150 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2022 | 412 | 0.150 |
Why?
| | Ornithine | 1 | 2018 | 26 | 0.150 |
Why?
| | Fasting | 1 | 2020 | 280 | 0.150 |
Why?
| | Asparagine | 1 | 2018 | 31 | 0.150 |
Why?
| | Models, Theoretical | 1 | 2022 | 575 | 0.150 |
Why?
| | Lipopolysaccharides | 1 | 2022 | 886 | 0.150 |
Why?
| | Pilot Projects | 1 | 2023 | 1692 | 0.150 |
Why?
| | Mental Health | 1 | 2024 | 716 | 0.140 |
Why?
| | Tobacco Smoke Pollution | 1 | 2021 | 261 | 0.140 |
Why?
| | Milk, Human | 1 | 2020 | 158 | 0.140 |
Why?
| | Carnitine | 1 | 2018 | 84 | 0.140 |
Why?
| | Feces | 1 | 2021 | 483 | 0.140 |
Why?
| | Phospholipids | 1 | 2019 | 222 | 0.140 |
Why?
| | Sleep | 1 | 2024 | 753 | 0.140 |
Why?
| | Comorbidity | 1 | 2023 | 1614 | 0.140 |
Why?
| | Infant, Small for Gestational Age | 1 | 2018 | 91 | 0.140 |
Why?
| | Immunoglobulin G | 1 | 2022 | 887 | 0.140 |
Why?
| | Economic Development | 1 | 2017 | 3 | 0.140 |
Why?
| | History, 21st Century | 1 | 2018 | 212 | 0.140 |
Why?
| | Pediatrics | 3 | 2024 | 1096 | 0.140 |
Why?
| | Mass Spectrometry | 2 | 2018 | 738 | 0.140 |
Why?
| | Health Promotion | 1 | 2023 | 734 | 0.130 |
Why?
| | Smoking | 1 | 2025 | 1620 | 0.130 |
Why?
| | Risk Assessment | 2 | 2024 | 3432 | 0.130 |
Why?
| | Energy Intake | 3 | 2025 | 484 | 0.130 |
Why?
| | Energy Metabolism | 2 | 2021 | 919 | 0.130 |
Why?
| | Snacks | 2 | 2015 | 19 | 0.130 |
Why?
| | Glucocorticoids | 1 | 2021 | 593 | 0.130 |
Why?
| | Dietary Fats | 2 | 2018 | 304 | 0.130 |
Why?
| | Mexican Americans | 1 | 2017 | 120 | 0.130 |
Why?
| | Prehypertension | 1 | 2015 | 28 | 0.120 |
Why?
| | Glucose | 1 | 2021 | 1019 | 0.120 |
Why?
| | Trans Fatty Acids | 1 | 2015 | 6 | 0.120 |
Why?
| | Cognition | 1 | 2023 | 1146 | 0.120 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2025 | 1242 | 0.120 |
Why?
| | Risk | 1 | 2018 | 908 | 0.120 |
Why?
| | Developing Countries | 1 | 2017 | 306 | 0.120 |
Why?
| | Absorptiometry, Photon | 1 | 2016 | 254 | 0.120 |
Why?
| | Anxiety | 1 | 2022 | 1031 | 0.120 |
Why?
| | Prognosis | 3 | 2021 | 4013 | 0.110 |
Why?
| | Pregnancy Trimesters | 1 | 2014 | 19 | 0.110 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2015 | 107 | 0.110 |
Why?
| | Body Weights and Measures | 1 | 2014 | 36 | 0.110 |
Why?
| | Aging | 2 | 2023 | 1864 | 0.110 |
Why?
| | Urban Population | 1 | 2017 | 476 | 0.110 |
Why?
| | Infant, Premature | 1 | 2018 | 566 | 0.110 |
Why?
| | New York City | 1 | 2013 | 85 | 0.110 |
Why?
| | Los Angeles | 1 | 2013 | 76 | 0.110 |
Why?
| | Adaptation, Physiological | 1 | 2018 | 549 | 0.110 |
Why?
| | Mitochondria | 1 | 2020 | 946 | 0.110 |
Why?
| | Epigenomics | 2 | 2024 | 115 | 0.100 |
Why?
| | Carbonated Beverages | 1 | 2013 | 16 | 0.100 |
Why?
| | Dietary Sucrose | 1 | 2013 | 49 | 0.100 |
Why?
| | Iron Overload | 1 | 2013 | 17 | 0.100 |
Why?
| | Food, Fortified | 1 | 2013 | 41 | 0.100 |
Why?
| | Nutrition Policy | 1 | 2013 | 61 | 0.100 |
Why?
| | Vitamin A | 1 | 2012 | 58 | 0.100 |
Why?
| | Ferritins | 1 | 2012 | 64 | 0.100 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2013 | 58 | 0.100 |
Why?
| | Animals | 6 | 2021 | 36847 | 0.100 |
Why?
| | Sweden | 1 | 2012 | 101 | 0.090 |
Why?
| | Maternal Age | 1 | 2012 | 129 | 0.090 |
Why?
| | CpG Islands | 2 | 2024 | 157 | 0.090 |
Why?
| | Vitamin B 12 | 1 | 2012 | 128 | 0.090 |
Why?
| | Bronchial Neoplasms | 1 | 2011 | 15 | 0.090 |
Why?
| | Folic Acid | 1 | 2012 | 185 | 0.090 |
Why?
| | Signal Transduction | 2 | 2022 | 5076 | 0.090 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2013 | 254 | 0.080 |
Why?
| | Immunization Programs | 1 | 2012 | 213 | 0.080 |
Why?
| | Genotype | 2 | 2025 | 1914 | 0.080 |
Why?
| | Iron | 1 | 2012 | 312 | 0.080 |
Why?
| | Obesity, Morbid | 1 | 2013 | 259 | 0.080 |
Why?
| | Diet Surveys | 2 | 2021 | 95 | 0.080 |
Why?
| | Zinc | 1 | 2012 | 297 | 0.080 |
Why?
| | Case-Control Studies | 3 | 2023 | 3540 | 0.070 |
Why?
| | Colonic Neoplasms | 1 | 2011 | 254 | 0.070 |
Why?
| | SRS-A | 1 | 1987 | 31 | 0.070 |
Why?
| | Disease Progression | 1 | 2015 | 2750 | 0.070 |
Why?
| | Medicaid | 1 | 2012 | 433 | 0.070 |
Why?
| | Severity of Illness Index | 2 | 2013 | 2822 | 0.070 |
Why?
| | Bronchial Provocation Tests | 1 | 1987 | 51 | 0.070 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 5742 | 0.070 |
Why?
| | Prednisolone | 1 | 1987 | 82 | 0.070 |
Why?
| | Muscles | 2 | 2022 | 325 | 0.070 |
Why?
| | Retrospective Studies | 2 | 2022 | 15504 | 0.070 |
Why?
| | Patient Acceptance of Health Care | 1 | 2013 | 805 | 0.070 |
Why?
| | Reproducibility of Results | 3 | 2024 | 3265 | 0.060 |
Why?
| | Mass Screening | 1 | 2013 | 1267 | 0.060 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2013 | 1322 | 0.060 |
Why?
| | Hot Flashes | 1 | 2025 | 87 | 0.050 |
Why?
| | Esters | 1 | 2024 | 76 | 0.050 |
Why?
| | Adenocarcinoma | 1 | 2011 | 938 | 0.050 |
Why?
| | Organophosphates | 1 | 2024 | 134 | 0.050 |
Why?
| | Academic Success | 1 | 2023 | 28 | 0.050 |
Why?
| | Parity | 1 | 2023 | 125 | 0.050 |
Why?
| | Accelerometry | 1 | 2023 | 99 | 0.050 |
Why?
| | Sugars | 1 | 2023 | 41 | 0.050 |
Why?
| | Oxylipins | 1 | 2023 | 40 | 0.050 |
Why?
| | Life Style | 2 | 2016 | 487 | 0.050 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2022 | 14 | 0.050 |
Why?
| | Polymorphism, Genetic | 1 | 2025 | 659 | 0.050 |
Why?
| | Starch | 1 | 2022 | 22 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2013 | 7585 | 0.050 |
Why?
| | Longevity | 1 | 2023 | 164 | 0.050 |
Why?
| | Proportional Hazards Models | 1 | 2024 | 1261 | 0.040 |
Why?
| | Cardiology | 1 | 2024 | 274 | 0.040 |
Why?
| | Food | 1 | 2022 | 160 | 0.040 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2022 | 159 | 0.040 |
Why?
| | Parents | 2 | 2024 | 1340 | 0.040 |
Why?
| | Allergens | 1 | 2024 | 408 | 0.040 |
Why?
| | Menstrual Cycle | 1 | 2022 | 133 | 0.040 |
Why?
| | Lipase | 1 | 2021 | 69 | 0.040 |
Why?
| | Leukocytes | 1 | 2022 | 311 | 0.040 |
Why?
| | Dietary Exposure | 1 | 2020 | 6 | 0.040 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2022 | 212 | 0.040 |
Why?
| | Louisiana | 1 | 2020 | 29 | 0.040 |
Why?
| | Alanine Transaminase | 1 | 2021 | 157 | 0.040 |
Why?
| | Consensus | 1 | 2023 | 678 | 0.040 |
Why?
| | Genetic Markers | 1 | 2021 | 344 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2022 | 404 | 0.040 |
Why?
| | Host-Parasite Interactions | 1 | 2021 | 114 | 0.040 |
Why?
| | Nutrition Assessment | 1 | 2020 | 91 | 0.040 |
Why?
| | Gene-Environment Interaction | 1 | 2021 | 190 | 0.040 |
Why?
| | Telomere | 1 | 2022 | 280 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 738 | 0.040 |
Why?
| | Eating | 1 | 2022 | 379 | 0.040 |
Why?
| | Quality of Life | 2 | 2025 | 2878 | 0.040 |
Why?
| | Genitalia | 1 | 2018 | 30 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3555 | 0.040 |
Why?
| | Edible Grain | 1 | 2018 | 49 | 0.040 |
Why?
| | Public Health | 1 | 2023 | 579 | 0.040 |
Why?
| | Behavior, Animal | 1 | 2021 | 497 | 0.040 |
Why?
| | Menarche | 1 | 2018 | 60 | 0.040 |
Why?
| | Cities | 1 | 2018 | 132 | 0.030 |
Why?
| | Particulate Matter | 1 | 2020 | 312 | 0.030 |
Why?
| | Testis | 1 | 2018 | 151 | 0.030 |
Why?
| | Breast | 1 | 2018 | 149 | 0.030 |
Why?
| | Meat | 1 | 2018 | 94 | 0.030 |
Why?
| | Social Class | 1 | 2019 | 281 | 0.030 |
Why?
| | Dietary Carbohydrates | 1 | 2018 | 155 | 0.030 |
Why?
| | Dietary Proteins | 1 | 2018 | 135 | 0.030 |
Why?
| | Autoimmunity | 1 | 2023 | 908 | 0.030 |
Why?
| | Lactation | 1 | 2018 | 181 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2018 | 433 | 0.030 |
Why?
| | Transcription Factors | 1 | 2024 | 1718 | 0.030 |
Why?
| | Pregnancy Trimester, Second | 1 | 2016 | 80 | 0.030 |
Why?
| | Oleic Acid | 1 | 2015 | 40 | 0.030 |
Why?
| | Linoleic Acid | 1 | 2015 | 43 | 0.030 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2015 | 54 | 0.030 |
Why?
| | Weight Loss | 1 | 2020 | 776 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2021 | 1163 | 0.030 |
Why?
| | Vitamin D | 1 | 2018 | 397 | 0.030 |
Why?
| | Research Design | 1 | 2020 | 1127 | 0.030 |
Why?
| | Notophthalmus viridescens | 1 | 1993 | 1 | 0.030 |
Why?
| | Aged | 1 | 2013 | 23794 | 0.030 |
Why?
| | Radio | 1 | 2013 | 2 | 0.030 |
Why?
| | Salamandridae | 1 | 1993 | 33 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2018 | 559 | 0.030 |
Why?
| | Tanzania | 1 | 2013 | 58 | 0.030 |
Why?
| | Depression | 1 | 2022 | 1396 | 0.030 |
Why?
| | Consumer Health Information | 1 | 2013 | 47 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2412 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1993 | 560 | 0.020 |
Why?
| | Information Systems | 1 | 2012 | 61 | 0.020 |
Why?
| | Acclimatization | 1 | 1993 | 177 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2018 | 1462 | 0.020 |
Why?
| | Models, Statistical | 1 | 2014 | 667 | 0.020 |
Why?
| | Models, Biological | 1 | 2018 | 1773 | 0.020 |
Why?
| | Reminder Systems | 1 | 2012 | 168 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2011 | 303 | 0.020 |
Why?
| | Digestive System Surgical Procedures | 1 | 2011 | 106 | 0.020 |
Why?
| | Chemoradiotherapy | 1 | 2011 | 225 | 0.020 |
Why?
| | Rural Population | 1 | 2013 | 560 | 0.020 |
Why?
| | Data Collection | 1 | 2012 | 668 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2011 | 657 | 0.020 |
Why?
| | Airway Resistance | 1 | 1987 | 36 | 0.020 |
Why?
| | Vaccines | 1 | 2012 | 405 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 10745 | 0.010 |
Why?
| | Phosphocreatine | 1 | 1993 | 46 | 0.010 |
Why?
| | Phosphates | 1 | 1993 | 182 | 0.010 |
Why?
| | Species Specificity | 1 | 1993 | 586 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1993 | 487 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1993 | 610 | 0.010 |
Why?
| | Temperature | 1 | 1993 | 675 | 0.010 |
Why?
|
|
Perng's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|